Sartorius Stedim Biotech operates as a total solutions provider for the biopharmaceutical industry. The company assists its customers in developing production processes and manufacturing biotech medications and vaccines more efficiently. Operating globally with subsidiaries in over 25 countries and approximately 11,900 employees worldwide, the parent company of the Sartorius Stedim Biotech Group is Sartorius Stedim Biotech S.A., headquartered in Aubagne, France, and listed on the Euronext stock exchange in Paris. Sartorius AG holds approximately 74% of the share capital and around 85% of the voting rights of Sartorius Stedim Biotech S.A.